Skip to main content
Premium Trial:

Request an Annual Quote

Emmanuelle Charpentier

Emmanuelle Charpentier is joining the Max Planck Institute for Infection Biology on Oct. 1 as scientific director, where she will set up a new department within the institute. She is a co-inventor of the CRISPR/Cas9 genome editing technology. Charpentier has been a professor at the Helmholtz Centre for Infection Resarch and Hannover Medical School and at the Laboratory for Molecular Infection Medicine at Umeå University.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.